{
    "medicine_id": "2e48da048ae261ab2afba517379a9996bd9e74c0",
    "platform_id": "DB05489",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v ACA 125",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in ovarian cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "An IgG1 murine monoclonal anti idiotype antibody Ab2 ACA 125 was developed to bind to anti CA 125 antibodies ACA 125 mimics the tumor associated antigen CA 125 which can be detected in about 80 of ovarian carcinomas It is therefore indicated for ovarian cancer",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}